TIMM9

Mitochondrial import inner membrane translocase subunit Tim9 · Q9Y5J7 · TIMM9 on Sugi Atlas →

0 patent compounds predicted against TIMM9, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TIMM9 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Impact if Desflurane Preconditioning on the Content of the Phospho-GSK-3b in the Rat's Neurons in the Model of I/R PHASE4WITHDRAWN
Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy PHASE3RECRUITING
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis PHASE2COMPLETED
Prevent Cardiac Surgery Associated AKI Trial PHASE2RECRUITING
The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC PHASE1/PHASE2UNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence nanNOT_YET_RECRUITING
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Identification of New Candidate Genes in Patients With Mitochondrial Disease by High Resolution Chromosome Analysis on DNA Chip nanCOMPLETED
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Natural History Study - Mitochondrial Disease nanRECRUITING
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) nanRECRUITING
Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy nanCOMPLETED
The Natural History of Mitochondrial Diseases nanRECRUITING
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability. nanUNKNOWN
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease nanRECRUITING
Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 nanCOMPLETED
Measuring Protein Turnover in Humans Across the Lifespan by Metabolic Labeling With Deuterium Oxide nanRECRUITING
Calf Muscle Strength in Mitochondrial Diseases nanCOMPLETED
Ccf mtDNA as a Neurodegenerative Biomarker nanUNKNOWN
Cerebrospinal Fluid Mitochondrial Biomarkers in Ischemic Stroke and Alzheimer Disease nanRECRUITING
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases nanRECRUITING
Cardiac Mitochondrial Function in Explanted Human Hearts nanUNKNOWN
Survey on Supplement Use in Mitochondrial Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TIMM9 binder may also engage these)

ProteinNameSimilarity
Q2KIV2 1.000 Q2KIV2 →
Q9WV98 1.000 Q9WV98 →
Q4V7R1 1.000 Q4V7R1 →
Q9W762 1.000 Q9W762 →
Q5ZIR8 1.000 Q5ZIR8 →
Q61TH2 1.000 Q61TH2 →
Q9WV97 1.000 Q9WV97 →
Q9WVA2 0.997 Q9WVA2 →
Q90YI5 0.996 Q90YI5 →
Q6C6Z2 0.995 Q6C6Z2 →
Q3SZ93 0.995 Q3SZ93 →
Q17754 0.994 Q17754 →
Q9VTN3 0.994 Q9VTN3 →
Q757S0 0.993 Q757S0 →
Q9Y1A3 0.993 Q9Y1A3 →
Q4FZG7 0.993 Q4FZG7 →
P57745 0.993 P57745 →
Q9Y0V3 0.992 Q9Y0V3 →
Q616Q2 0.992 Q616Q2 →
Q6FRT3 0.992 Q6FRT3 →
Q6BU42 0.992 Q6BU42 →
O74700 0.991 O74700 →
Q63ZH8 0.991 Q63ZH8 →
Q8J1Z1 0.991 Q8J1Z1 →
Q59R24 0.991 Q59R24 →
Q4QR62 0.991 Q4QR62 →
Q9Y8C0 0.991 Q9Y8C0 →
Q6BN23 0.990 Q6BN23 →
Q66L32 0.990 Q66L32 →
Q4PGT2 0.990 Q4PGT2 →